Valuation: RaySearch Laboratories AB

Market Cap 5.93B 604M 526M 498M 453M 846M 57.88B 850M 2.29B 29.41B 2.27B 2.22B 94.16B P/E 2026 *
22.1x
P/E 2027 * 17.7x
Enterprise Value 6.09B 620M 540M 511M 464M 868M 59.39B 872M 2.35B 30.18B 2.33B 2.28B 96.62B EV / Sales 2026 *
4.36x
EV / Sales 2027 * 3.64x
Free-Float
80.09%
Yield 2026 *
2.27%
Yield 2027 * 2.7%
1 day+0.51%
1 week+0.51%
Current month-1.55%
1 month-7.88%
3 months-14.62%
6 months-6.03%
Current year-22.11%
1 week 169.6
Extreme 169.6
179.6
1 month 166.7
Extreme 166.7
193
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
267
3 years 78.4
Extreme 78.4
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/18/26 Sell

Chief Technology Officer

-3,203 0.0104%
8/17/26 Sell

Chief Technology Officer

-2,297 0.0075%
6/11/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+0.51%-32.34%+122.56% 604M
-0.19%+0.18%-5.81%+26.26% 42.7B
+0.21%+1.62%-42.50%+131.21% 12.57B
-3.98%+4.34%-4.66%+110.14% 5.91B
+1.54%-0.02%+53.54% - 4.31B
-2.83%+5.73% - - 2.2B
-1.24%-1.68%+1.38%-40.13% 1.49B
+1.06%-0.52%-38.30% - 1.02B
-1.28%-2.15%+13.35%+151.76% 1B
+3.94%+1.10%+34.19%+50.07% 878M
Average -0.24%+3.30%-2.35%+78.84% 7.27B
Weighted average by Cap. -0.37%+2.21%-8.40%+55.75%

Financials

2026 *2027 *
Net sales 1.4B 142M 124M 117M 107M 199M 13.62B 200M 540M 6.92B 534M 522M 22.16B 1.63B 166M 145M 137M 124M 232M 15.91B 234M 631M 8.09B 624M 610M 25.89B
Net income 272M 27.7M 24.13M 22.84M 20.75M 38.76M 2.65B 38.95M 105M 1.35B 104M 102M 4.32B 338M 34.37M 29.94M 28.34M 25.74M 48.1M 3.29B 48.33M 131M 1.67B 129M 126M 5.36B
Net Debt 155M 15.79M 13.75M 13.01M 11.82M 22.09M 1.51B 22.2M 59.93M 768M 59.3M 57.98M 2.46B 7M 713K 621K 588K 534K 998K 68.28M 1M 2.71M 34.7M 2.68M 2.62M 111M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
26-09-18 SEK 177.50 +0.57% 42,939
26-09-17 SEK 176.50 +2.86% 417,138
26-09-16 SEK 171.60 -1.27% 140,746
26-09-15 SEK 173.80 +0.46% 71,843
26-09-14 SEK 173.00 -2.09% 152,730
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
176.50SEK
Average target price
297.50SEK
Spread / Average Target
+68.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!